Safe for All Fitzpatrick Types: Ultra-Short Pulse Laser Technology
Aerolase's ultra-short pulse technology delivers superior clinical outcomes across all skin types. Our 650-microsecond Nd:YAG and 300-microsecond Er:YAG systems treat 30+ FDA-cleared conditions—from acne and rosacea to resurfacing and anti-aging—with unmatched efficacy, patient comfort, and practice efficiency.
Universal Treatment Capability
- Safely and effectively treats all Fitzpatrick types (I-VI) across both non-ablative and ablative protocols.
Versatile Indication Coverage
- Address medical dermatology (acne, rosacea, PFB, onychomycosis, psoriasis) and aesthetic concerns (wrinkles, scars, pigmentation, vascular lesions).
Optimized Clinical Performance
- Ultra-short pulse durations deliver precise therapeutic endpoints without thermal damage, cooling requirements, or downtime.
Why Aerolase Outperforms Traditional Laser Systems
Aerolase doesn't just treat skin differently—it redefines what's possible. Our ultra-short pulse technology delivers results that traditional lasers simply can't achieve, transforming both patient outcomes and practice performance.
Results That Actually Work
- Treat acne, rosacea, and pigmentation with 87% average clearance—across every skin type, every time.
- No PIH complications. No thermal damage. No disappointed patients. Just consistent, visible improvements that keep them coming back.
Double Your Treatment Capacity
- See 4-6 patients per hour with 10-15 minute treatments.
- No cooling setup. No numbing time. No consumables eating your margins.
- While competitors schedule 80-120 treatments monthly, your practice runs 200+—and patients walk out with zero downtime.
Ease of Use for Everyone
- Forget IPL filter changes, cooling calibration, and endless test spots.
- One device. Multiple indications. Consistent parameters.
- Your staff achieves expert results from day one—no matter the patient's skin type or condition.
Revenue That Makes Sense
- Boost your practice’s profitability with Aerolase.
- Deliver exceptional outcomes, expand your services, and establish a rewarding business model that meets both patient and practitioner needs.
What makes Aerolase's 650-microsecond technology different from other lasers?
The 650-microsecond pulse duration delivers high-powered energy in an ultra-short burst, allowing precise targeting of melanin, hemoglobin, and water without excessive thermal damage. This enables safe treatment across all Fitzpatrick skin types (I-VI), including darker skin tones that risk hyperpigmentation with longer pulse durations used by traditional lasers.
What is the typical ROI timeline for purchasing a Neo Elite?
Most practices achieve ROI within 6-12 months. With acne treatments priced at $200-400 per session and patients requiring 4-6 treatments, a single patient can generate $2,400-$3,600 in revenue. The Neo Elite treats 36+ FDA-approved indications, allowing you to treat multiple indications anywhere on the body, creating multiple revenue streams from one device investment.
How does Aerolase compare to Cutera, Candela, or Cynosure devices?
Aerolase differentiates from Cutera, Candela, and Cynosure through its proprietary 650-microsecond pulse technology that emphasizes regenerative aesthetics rather than controlled tissue destruction. Unlike competitors requiring cooling systems (Candela's cryogen spray, Cutera's sapphire cooling), Aerolase treatments are virtually painless with no anesthetics or consumables, reducing operating costs. The Neo Elite treats 36+ FDA-cleared indications with one handpiece and is safe for all Fitzpatrick skin types (I-VI), while competitors often require multiple devices—Alexandrite for lighter skin and Nd:YAG for darker skin. While Candela and Cynosure excel at high-volume hair removal with larger spot sizes (up to 28mm) and faster treatment speeds, and Cutera's Excel V+ dominates vascular-focused treatments with dual wavelengths, Aerolase positions as the innovative choice for practices seeking a versatile, patient-friendly platform that stimulates natural collagen production across diverse treatment applications without the consumable costs and complexity of legacy laser systems.
Is Aerolase FDA-cleared, and for which indications?
Yes, Aerolase devices are FDA-cleared for 36+ indications including acne vulgaris, rosacea, pseudofolliculitis barbae, melasma, benign pigmented lesions, vascular lesions, wrinkles, scars, onychomycosis, psoriasis, and verrucae. This broad clearance allows practices to address multiple patient concerns with a single platform.
Is Aerolase safe for darker skin tones (Fitzpatrick IV-VI)?
Absolutely. Aerolase is specifically designed for safe treatment of all Fitzpatrick skin types (I-VI) with minimal risk of post-inflammatory hyperpigmentation. The 650-microsecond pulse duration and lack of epidermal contact eliminate the burning and PIH risks commonly associated with other laser treatments on darker skin.
Can Aerolase integrate with existing aesthetic service offerings?
Yes, Aerolase complements existing services including injectables (Botox, fillers), chemical peels, microneedling, and skincare protocols. The device enhances overall skin quality and is often incorporated into combination treatment packages. Many practitioners use it as a foundation treatment before or alongside injectables for superior results.
What's the patient downtime after Aerolase treatments?
There is essentially no downtime with Aerolase. Patients may experience mild, transient redness immediately following treatment that typically resolves within hours. No crusting, peeling, or social downtime occurs, allowing patients to return to work and normal activities immediately—a significant advantage over ablative or traditional laser treatments.